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To overcome structural barriers to providing opioid agonist therapy (OAT) in primary 
care settings, we propose building on the existing infrastructure of anticoagulation 
clinics. These clinics are well equipped to provide drug-monitoring and multidisciplinary 
support for medications through pharmacy and/or nurse-led teams. This proposal would 
use existing resources to expand current anti-coagulation clinics’ capabilities to include 
OAT.   
 
As primary care physicians work to decrease opiate prescribing for chronic pain, more 
patients requiring treatment for opioid use disorders will be identified.  Accordingly, 
policymakers internationally are calling to develop effective, scalable primary care 
models to increase access to therapies such as opioid agonist therapy (OAT).  Globally, 
much of Europe, Australia, and Canada have already been using general practitioners to 
prescribe not only buprenorphine, but also methadone (1, 2). The World Health 
Organization has attested that in order to ensure the quality of OAT programs, care 
models in any setting need to follow national and international guidelines, be 
multidisciplinary, provide social and behavioral support, maintain a non-stigmatizing 
environment, and be patient-centered (1).  Primary care-based multidisciplinary models 
that deliver OAT in the form of medication management clinics would meet these criteria 
whilst also providing logistical support to an already overburdened primary care 
workforce. 
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 The necessary infrastructure for such medication management clinics already exists. 
Anticoagulation clinics, providing interdisciplinary medication management and 
monitoring for patients on warfarin, have been established in over 3,000 care delivery 
settings internationally. Warfarin, similar to buprenorphine and methadone, requires 
frequent lab monitoring, ongoing patient education, and protocols for dose adjustment. 
An analogous OAT protocol design could easily account for the specific needs of patients 
during the induction, maintenance, and stabilization phases of treatment.  In addition, 
anticoagulation clinics are already well equipped to support both specialty and primary 
care physicians.  Staffed by pharmacists, nurses, and/or nurse practitioners, these 
providers could conduct monitoring, patient education and counseling, and when 
authorized, implement dosing changes.  This design would also be well suited to help 
support collaboration with multiple specialty providers, especially important when 
available pain specialists do not have addiction expertise.  In this collaborative care 
approach, the nurses and pharmacists serve as liaisons between the primary care team and 
specialists. In addition, as newer direct oral anticoagulants that require less frequent 
laboratory monitoring are increasingly replacing warfarin for treatment of common 
cardiovascular conditions, anticoagulation clinics should have more capacity to start to 
manage other medications.   
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Re-purposing these clinics to safely manage multiple classes of drugs would reduce the 
start-up burden and cost of finding trained personnel and physical space to start OAT 
clinics. Moreover, by providing the familiarity of a parallel care structure and supports, 
primary care physicians may be more likely to take on the challenge of providing 
buprenorphine for patients with opioid addiction.  Similarly, health care systems would 
be more likely to invest in a previously tested model that provides high quality care and 
lowers costs through reductions in hospitalizations and emergency department visits(3).   
 
Logistical barriers are among the most commonly cited reasons by primary care 
physicians for not prescribing OAT(4). In addition, critics of increasing primary care-
based prescribing of OAT often express concern for drug safety. The tools of OAT safety 
include checking prescription drug monitoring programs, drug contracts, pill counts, and 
urine toxicology screens to monitor for drug misuse and diversion. Medication 
management clinics offer a solution to the burden of this monitoring, as this structure 
provides a cost-effective, high quality model to support primary care physicians in safe 
prescribing practices.   
 
What are the real advantages of repurposing traditional anticoagulation clinic model to 
also serve as OAT medication management clinics? Addiction, unlike diseases 
warranting anticoagulation, is highly stigmatized, and these clinics would also need to 
This article is protected by copyright. All rights reserved.
work towards overcoming stigma-related barriers.  In order to be successful, medication 
management clinics would have to move beyond just managing medication dosing and 
drug monitoring protocols, and focus on offering multiple patient-centered benefits with 
respect to providing an integrated approach to managing addiction.  First, these clinics 
could foster a less stigmatizing environment where patients are more likely to engage in 
care, relative to traditional OAT clinics in specialty addictions clinics. Second, the 
pharmacist/nurse leaders of the clinic could offer patients more dedicated time to address 
their concerns with respect to their addiction and building trust with the medical team.   
Finally, this multidisciplinary approach could provide more dedicated time for patient 
education and behavioral counseling to encourage adherence to medication regimens 
which may not be possible by primary care physicians who are practising alone.  
 
There is precedent for using a similar multi-disciplinary team structure in the setting of 
managing long-term opioid prescriptions.  Researchers at the Philadelphia Veterans 
Affairs Medical Center tested a nurse practitioner- and clinical pharmacist-led model, 
aided by a multi-specialty pain team, to help support primary care providers follow 
opioid prescribing guidelines for patients with non-cancer chronic pain(5).  After two 
years, the model had increased primary care provider satisfaction, saved pharmacy costs, 
and decreased medication misuse(5)(4).  
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Although OAT management for patients with substance use disorders is not completely 
analogous to opiate management for patients with chronic pain, there are similar 
requirements in terms of a need for multi-specialty care (e.g., mental/behavioral health, 
primary care, and pain management), stigmatization, and possessing a need to monitor 
for medication misuse and diversion.  In the OAT medication management model, the clinics could also play a critical role within health systems of identifying and treating patients with chronic pain who have developed a co-occurring opioid use disorder.    
 
Successful innovation often relies on re-inventing prior solutions and learning from other 
disciplines.  When it comes to OAT, we should consider capitalizing on the infrastructure 
and workforce that exists within anticoagulation clinics, especially as their demand to 
manage warfarin decreases.  These clinics have the potential to foster an environment of 
support and empathy where patients are going to heal rather than be chastised for their 
addiction.  This inventive re-interpretation of an existing model has the potential to 
increase access to high quality care, lower health care costs, provide patient-centered 
care, and allow more time for primary care physicians to manage diseases rather than 
drugs.  We are in dire need of a readily available, effective solution to help curtail opioid 
related deaths.  OAT medication management clinics in primary care may be the answer.   
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